The serum levels of the prostate specific antigen (PSA) protein increase in untreated castration resistant prostate cancer (CRPC) patients as reactivation of AR activity in prostate cancer cells drives the transcription of AR target genes such as PSA. The gene discussed is KLK3; the disease is prostate cancer.